Correlation Between Cryoport and Entrada Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cryoport and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cryoport and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cryoport and Entrada Therapeutics, you can compare the effects of market volatilities on Cryoport and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cryoport with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cryoport and Entrada Therapeutics.

Diversification Opportunities for Cryoport and Entrada Therapeutics

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cryoport and Entrada is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Cryoport and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Cryoport is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cryoport are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Cryoport i.e., Cryoport and Entrada Therapeutics go up and down completely randomly.

Pair Corralation between Cryoport and Entrada Therapeutics

Given the investment horizon of 90 days Cryoport is expected to generate 1.98 times less return on investment than Entrada Therapeutics. In addition to that, Cryoport is 1.61 times more volatile than Entrada Therapeutics. It trades about 0.09 of its total potential returns per unit of risk. Entrada Therapeutics is currently generating about 0.28 per unit of volatility. If you would invest  1,714  in Entrada Therapeutics on September 1, 2024 and sell it today you would earn a total of  275.00  from holding Entrada Therapeutics or generate 16.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Cryoport  vs.  Entrada Therapeutics

 Performance 
       Timeline  
Cryoport 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cryoport has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Entrada Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Cryoport and Entrada Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cryoport and Entrada Therapeutics

The main advantage of trading using opposite Cryoport and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cryoport position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.
The idea behind Cryoport and Entrada Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio